| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
9,000,000 |
| Market
Cap: |
1.53(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.15 - $0.939 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Histogen is a biotechnology company focusing on the development and commercialization of medicines to treat chronic diseases.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-29 |
2023-11-28 |
2023-05-30 |
2022-05-30 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Vandertie Michelle L |
Vice President, FinanceOfficer |
• – – |
2017-03-31 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
4,978 |
|
- |
|
| Ripley Daniel L. |
SVP, Bus Dev, P&A MgmtOfficer |
• – – |
2017-01-26 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
27,701 |
|
- |
|
| Cashion Charles |
SVP, Finance, CFO and Sec. |
• – – |
2017-01-09 |
4 |
OE |
$0.99 |
$42,000 |
D/D |
42,424 |
42,424 |
|
- |
|
| Kisner Daniel L |
Director |
– • – |
2016-12-28 |
4 |
A |
$0.00 |
$0 |
I/I |
2,310 |
5,455 |
|
- |
|
| Mento Steven J |
President, CEO & Director |
• • – |
2016-12-20 |
4 |
OE |
$0.99 |
$50,091 |
D/D |
41,414 |
41,414 |
|
- |
|
| Van Wart Harold |
Director |
– • – |
2016-10-27 |
4 |
OE |
$0.25 |
$4,545 |
D/D |
18,181 |
18,181 |
|
- |
|
| Kisner Daniel L |
Director |
– • – |
2015-04-08 |
4 |
B |
$5.75 |
$23,000 |
D/D |
4,000 |
7,145 |
2.39 |
- |
|
| Cashion Charles |
SVP, Finance, CFO and Sec. |
• – – |
2014-04-02 |
5 |
GD |
$0.00 |
$0 |
I/I |
5,000 |
144,738 |
|
- |
|
| Kisner Daniel L |
Director |
– • – |
2014-02-19 |
4/A |
A |
$0.00 |
$0 |
I/I |
3,145 |
3,145 |
|
- |
|
| Aberdare Partners Iii Lp |
Former 10% Owner |
– – – |
2014-02-19 |
4 |
D |
$0.00 |
$0 |
I/I |
(1,350,439) |
0 |
|
- |
|
| Aberdare Partners Iii Lp |
Former 10% Owner |
– – – |
2014-02-19 |
4 |
A |
$0.00 |
$0 |
I/I |
36,634 |
36,634 |
|
- |
|
| Kisner Daniel L |
Director |
– • – |
2014-02-19 |
4 |
A |
$0.00 |
$0 |
D/D |
3,145 |
3,145 |
|
- |
|
| Klingenstein Paul H |
Director |
– • – |
2014-02-19 |
4 |
A |
$0.00 |
$0 |
I/I |
45,365 |
8,731 |
|
- |
|
| Klingenstein Paul H |
Director |
– • – |
2014-02-19 |
4 |
A |
$0.00 |
$0 |
D/D |
20,322 |
20,322 |
|
- |
|
| Klingenstein Paul H |
Director |
– • – |
2014-02-19 |
4 |
D |
$0.00 |
$0 |
I/I |
(1,350,439) |
0 |
|
- |
|
| Hale David F |
Director |
– • – |
2014-01-08 |
4 |
OE |
$0.99 |
$12,000 |
D/D |
12,121 |
24,242 |
|
- |
|
| Hale David F |
Director |
– • – |
2013-09-26 |
4 |
OE |
$2.31 |
$28,000 |
D/D |
12,121 |
12,121 |
|
- |
|
| Malik Shahzad |
Director |
– • • |
2013-07-30 |
4 |
B |
$11.00 |
$2,090,594 |
I/I |
190,054 |
2,166,836 |
2.25 |
- |
|
| Malik Shahzad |
Director |
– • • |
2013-07-30 |
4 |
A |
$11.00 |
$211,453 |
I/I |
19,223 |
1,976,782 |
|
- |
|
| Malik Shahzad |
Director |
– • • |
2013-07-30 |
4 |
S |
$11.00 |
$5,885 |
I/I |
(535) |
1,957,559 |
|
- |
|
| Malik Shahzad |
Director |
– • • |
2013-07-30 |
4 |
OE |
$0.08 |
$5,775 |
I/I |
70,003 |
1,958,094 |
|
- |
|
| Malik Shahzad |
Director |
– • • |
2013-07-30 |
4 |
A |
$0.00 |
$0 |
I/I |
1,888,091 |
1,888,091 |
|
- |
|
| Perret Marc Olivier |
Director |
– • • |
2013-07-30 |
4 |
B |
$11.00 |
$1,820,775 |
I/I |
165,525 |
1,487,320 |
2.25 |
- |
|
| Perret Marc Olivier |
Director |
– • • |
2013-07-30 |
4 |
A |
$11.00 |
$184,162 |
I/I |
16,742 |
1,321,795 |
|
- |
|
| Perret Marc Olivier |
Director |
– • • |
2013-07-30 |
4 |
S |
$11.00 |
$3,872 |
I/I |
(352) |
1,305,053 |
|
- |
|
99 Records found
|
|
Page 2 of 4 |
|
|
